Article

Depressive Symptoms, Substance Use, and HIV-Related High-Risk Behaviors Among Opioid-Dependent Individuals: Results From the Clinical Trials Network

Department of Epidemiology and Psychiatry, Columbia University, New York City, New York 10032, USA.
Substance Use &amp Misuse (Impact Factor: 1.23). 10/2011; 46(14):1716-25. DOI: 10.3109/10826084.2011.611960
Source: PubMed

ABSTRACT The sample included 343 opioid-dependent adults enrolled in two national multisite studies of the National Drug Abuse Treatment Clinical Trials Network (CTN001-002). Opioid-dependent individuals were recruited from 12 sites across the United States from January 2001 to July 2002. We examined associations between depressive symptoms, co-occurring substance use (i.e., the use of substances other than opioids), and HIV-related sexual and injection risk behaviors. Data were collected using the Addiction Severity Index and the HIV Risk Behavior Scale, and analyzed using linear regression. Depressive symptoms were associated with an increased level of injection risk behaviors but were not associated with risky sexual behaviors. The co-occurring use of amphetamines also increased the likelihood of risky sexual behaviors. The study limitations and clinical implications are noted. The study was funded by the U.S. National Institute on Drug Abuse.

Download full-text

Full-text

Available from: Li-Tzy Wu, Aug 29, 2015
0 Followers
 · 
100 Views
  • Source
    • "Several studies have investigated the relationship between depression and drug use, with the prevalence of depression among IDU ranging from 25% to 81% (Callaly et al., 2001; Springer, 2012; Teesson et al., 2005; Pilowsky et al., 2011; Conner et al., 2008; Mackesy-Amiti et al., 2012). A meta-analysis of 55 studies investigating the association between depression and substance related behaviors among IDU identified 55% of participants with above average levels of depressive symptoms (Conner et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVES: Non-fatal overdose remains a significant source of morbidity among people who inject drugs (IDU). Although depression and social support are important in shaping the health of IDU, little is known about the relationship between these factors and overdose. Therefore, we sought to determine whether depressive symptoms and social support predicted non-fatal overdose among IDU in a Canadian setting. METHODS: Data were derived from three prospective cohorts of people who use drugs: the Vancouver Injection Drug Users Study (VIDUS), the ACCESS Cohort, and the At-Risk Youth Study (ARYS). Multilevel modeling was used to determine if depression and social support were significant predictors of non-fatal overdose across time. Analyses were stratified by sex. RESULTS: There were 1931 participants included in this analysis, including 653 (33.8%) females and 69 (3.6%) youth 20 years old or younger. Depressed men (adjusted odds ratio [AOR]=1.53, 95% confidence intervals [CI]=1.25, 1.87) and women (adjusted odds ratio [AOR]=2.23, 95% confidence intervals [CI]=1.65, 3.00) were more likely to experience a non-fatal overdose. Further, among women, those who reported having 3 or more persons they could rely upon for social support were less likely to experience a non-fatal overdose (AOR=0.54, 95% CI 0.31, 0.93). CONCLUSION: Although depression was a significant predictor of non-fatal drug overdose, social support was a significant predictor among women only. Possible strategies to prevent non-fatal overdose may include identifying IDU experiencing severe depressive symptoms and providing targeted mental health treatments and mobilizing interpersonal social support among IDU, especially among women.
    Drug and alcohol dependence 05/2013; 132(3). DOI:10.1016/j.drugalcdep.2013.04.007 · 3.28 Impact Factor
  • Source
    • "Nonaddictive mental illnesses can also increase unsafe injection-drug use practices. In a study of 343 opioid-dependent adults recruited from 12 sites across the United States and enrolled in multisite studies of the National Drug Abuse Treatment Clinical Trials Network (CTN001-002), depressive symptoms were associated with an increased level of injection risk behaviors [23]. Past suicide attempts were associated with a history of drug injection among almost 7,000 Swedish criminal justice clients with suspected substance-related problems [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: People who inject drugs are more likely to be HIV positive and to have a mental disorder than the general population. We explore how the detection and treatment of mental illness among people who are injecting drugs are essential to primary and secondary prevention of HIV infection in this population. Aside from opioid addiction, few studies have been conducted on the links between mental disorders and injection-drug use. However, independent of the injection-drug use literature, a growing number of studies demonstrate that untreated mental illness, especially depression and alcohol/substance use disorders, is associated with HIV-related risk behaviors, acquiring HIV infection, failure to access HIV care and treatment, failure to adhere to HIV care and treatment, and increased morbidity and mortality from HIV-related diseases and comorbidities. In our review of both the published literature and gray literature we found a dearth of information on models for providing care for both opioid addiction and other mental illnesses regardless of HIV status, particularly in low- and middle-income countries. We therefore make recommendations on how to address the mental health needs of HIV-positive people who inject drugs, which include the provision of opioid substitution therapy and integrated mental health, substance abuse, and HIV services.
    01/2013; 2013:690386. DOI:10.1155/2013/690386
  • Source
    Journal of Infant Child and Adolescent Psychotherapy 10/2012; 11:376-386. DOI:10.1080/15289168.2012.735183
Show more